Moleculin Biotech Inc (MBRX NASDAQ) stock market data APIs
$8.6481
-0.17(-2%)
as of November 5, 2026
Try our APIs with
free plan!
Moleculin Biotech Inc Financial Data Overview
Price chart is built with
Anychart
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose that cut off the energy supply of tumors. The company was incorporated in 2015 and is headquartered in Houston, Texas.
Prev. Close
8.6481
Open
8.4784
High
8.9344
Low
7.7443
52 wk Range
3.228-253.05
Market Cap
8 898 K
P/E Ratio
0.0486
Shares Outstanding
1 019 K
EPS
-1.4
Beta
2.09
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Moleculin Biotech Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Moleculin Biotech Inc data using free add-ons & libraries
Get Moleculin Biotech Inc Fundamental Data
Moleculin Biotech Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -28 828 000
- Earnings Per Share: 179
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-13
- EPS/Forecast: -1.55
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Moleculin Biotech Inc News
New
Moleculin announces 1-for-20 reverse stock split, shares slide
* Moleculin Biotech (MBRX [https://seekingalpha.com/symbol/MBRX]) on Friday announced a 1-for-20 reverse stock split of its common stock, effective October 20, 2026. * Shares of Moleculin fell ov...
Moleculin Announces Reverse Stock Split
Moleculin Biotech, Inc. HOUSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), today announced that it filed an amendment to its amended an...
Moleculin Biotech GAAP EPS of -$1.40 misses by $0.53
* Moleculin Biotech press release [https://seekingalpha.com/pr/20619725-moleculin-biotech-reports-second-quarter-2026-financial-results-and-highlights-continued] (MBRX [https://seekingalpha.com/symb...
Moleculin Announces Pricing of $9.3 Million Public Offering
HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced the pricing of a best-efforts public offering of an aggrega...
Get Moleculin Biotech Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.